Luca Ceriani

18PUBLICATIONS
121CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Animal physiology - cell
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 12, 2025
Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial.

Emanuele Zucca, Luca Ceriani, Giovannino Ciccone

|May 13, 2025
A comprehensive genetic study of classic Hodgkin lymphoma using circulating tumor DNA.

Maria Cristina Pirosa, Alessio Bruscaggin, Lodovico Terzi di Bergamo

|Apr 15, 2025
Understandings 18 FDG PET radiomics and its application to lymphoma.

Luca Ceriani, Lisa Milan, Stephane Chauvie

|Aug 19, 2024
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results.

Maurizio Martelli, Luca Ceriani, Giovannino Ciccone

|Mar 31, 2023
Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma.

J J Eertink, G J C Zwezerijnen, M W Heymans

|Jul 13, 2022
Dmax : A simple and reliable PET/CT-derived new biomarker of lymphoma outcome?

Luca Ceriani, Emanuele Zucca

Pageof 3

Frequent Collaborators

11 joint publications

Emanuele Zucca

5 joint publications

Luca Giovanella

4 joint publications

N George Mikhaeel

3 joint publications

Alessandra Tucci